|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print March 13, 2002
Am J Physiol Gastrointest Liver Physiol, 10.1152/ajpgi.00073.2001
Submitted on February 20, 2001
Accepted on January 24, 2002
-Melanocyte Stimulating Hormone Protects Against Mesenteric Ischemia/Reperfusion Injury
1 Department of Surgery, The University of Texas Medical School at Houston, Houston, TX, USA
2 Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, TX, USA
3 Department of Integrative Biology and Pharmacology and The Trauma Research Center, The University of Texas Medical School at Houston, Houston, TX, USA
4 Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, TX, USA; Department of Integrative Biology and Pharmacology and The Trauma Research Center, The University of Texas Medical School at Houston, Houston, TX, USA
* To whom correspondence should be addressed. E-mail: Bruce.C.Kone{at}uth.tmc.edu.
Mesenteric ischemia/reperfusion (I/R) injury to the intestine is a common and often devastating clinical occurrence for which there are few therapeutic options.
-Melanocyte-stimulating hormone (
-MSH) is a tridecapeptide released by the pituitary gland and immunocompetent cells that exerts anti-inflammatory actions and abrogates post-ischemic injury to the kidneys and brainstem of rodents. To test the hypothesis that
-MSH would afford similar protection in the post-ischemic small intestine, we analyzed the effects of this peptide on intestinal transit, histology, myeloperoxidase activity, and NF-
B activation following 45 min of superior mesenteric artery occlusion and up to 6 hours of reperfusion. Rats subjected to I/R exhibited markedly depressed intestinal transit, histologic evidence of severe injury to the ileum, increased myeloperoxidase activity in ileal cytoplasmic extracts, and biphasic activation of NF-
B in ileal nuclear extracts. In contrast, rats treated with
-MSH before I/R exhibited intestinal transit and histologic injury scores comparable to those of sham-operated controls. In addition, the
-MSH-treated rats demonstrated less I/R-induced activation of intestinal NF-
B and myeloperoxidase activity after prolonged (6 hours) reperfusion. We conclude that
-MSH significantly limits post-ischemic injury to the rat small intestine.
This article has been cited by other articles:
![]() |
E. K. Robinson, D. P. Kelly, D. W. Mercer, and R. A. Kozar Differential Effects of Luminal Arginine and Glutamine on Metalloproteinase Production in the Postischemic Gut JPEN J Parenter Enteral Nutr, July 1, 2008; 32(4): 433 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. McQuiggan, R. Kozar, R. M. Sailors, C. Ahn, B. McKinley, and F. Moore Enteral Glutamine During Active Shock Resuscitation Is Safe and Enhances Tolerance of Enteral Feeding JPEN J Parenter Enteral Nutr, January 1, 2008; 32(1): 28 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Catania The melanocortin system in leukocyte biology J. Leukoc. Biol., February 1, 2007; 81(2): 383 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Catania, S. Gatti, G. Colombo, and J. M. Lipton Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation Pharmacol. Rev., March 1, 2004; 56(1): 1 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Montalto, M. L. Hart, J. E. Jordan, K. Wada, and G. L. Stahl Role for complement in mediating intestinal nitric oxide synthase-2 and superoxide dismutase expression Am J Physiol Gastrointest Liver Physiol, June 9, 2003; 285(1): G197 - G206. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zou, B. Attuwaybi, and B. C. Kone Effects of NF-kappa B inhibition on mesenteric ischemia-reperfusion injury Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G713 - G721. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |